Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Corvus Pharmaceuticals, Inc. (CRVS)
Sector: Healthcare; Industry: Biotechnology

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in Phase I/Ib clinical trial for adenosine, an immune checkpoint.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-17 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 1,285,714 $3.50 $4,499,999 No
2019-08-06 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 142,656 $3.51 $500,723 No
2019-07-01 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 657,344 $3.72 $2,444,065 No
2018-03-12 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 588,235 $8.50 $4,999,998 No
2016-06-24 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 1,000 $12.98 $12,983 No
2016-06-21 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 38,383 $12.75 $489,192 No
2016-06-16 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 20,000 $12.35 $247,000 No
2016-06-10 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 50,000 $12.96 $648,100 No
2016-05-20 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 4,716 $13.09 $61,732 No
2016-05-19 ORBIMED ADVISORS LLC Director Buy 6,800 $11.77 $80,035 No
2016-03-29 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 550,000 $15.00 $8,250,000 Yes

Insider Smart

Planet Fitness, Inc (PLNT) - Our position in PLNT is also inspired by insider trading, if insiders are comfortable and confident buying around $50, it is an easy hold if you can pick it up at an even lower price. Our avg cost of the position is ~$40 and is now with 50% profit.

Insider Smart

VBI Vaccines Inc (VBIV) - Since 10%-owner Perceptive Advisor LCC increased their holding in April, the stock have double the price. Impressive!